Arkolith/Insider Trading/CRBP/Form 4

Cormorant Global Healthcare Master Fund, LP

10% OwnerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Sep 24, 2024
Net Buying
Open-Market Buys
$7.0M
Open-Market Sells
$0
Net Open-Market Flow
$7.0M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2024Buy(P)26K$18.36$476K2.1M
Sep 20, 2024Buy(P)45K$17.48$788K2.1M
Sep 20, 2024Buy(P)26K$22.23$573K2.4M
Sep 20, 2024Buy(P)140K$20.42$2.8M2.3M
Sep 20, 2024Buy(P)66K$19.61$1.3M2.2M
Sep 20, 2024Buy(P)48K$21.47$1.0M2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-24-003217) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML